| Record ID | ia:humanimmunodefic0000unse_h8n9 |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/humanimmunodefic0000unse_h8n9/humanimmunodefic0000unse_h8n9_marc.xml |
| Download MARC binary | https://www.archive.org/download/humanimmunodefic0000unse_h8n9/humanimmunodefic0000unse_h8n9_meta.mrc |
LEADER: 03587cam 22006374a 4500
001 ocm48065389
003 OCoLC
005 20200925094623.0
008 010928s2002 njua b 001 0 eng
010 $a 2001096473
040 $aDLC$beng$cDLC$dNLM$dUKM$dGUA$dVVC$dLVB$dBAKER$dBTCTA$dYDXCP$dIG#$dBDX$dNHA$dOCLCQ$dOCLCF$dOCLCO$dOCLCA
015 $aGBA1V3255$2bnb
016 7 $a101141274$2DNLM
019 $a59432257$a985482260$a985626839
020 $a0691004544$q(alk. paper)
020 $a9780691004549$q(alk. paper)
035 $a(OCoLC)48065389$z(OCoLC)59432257$z(OCoLC)985482260$z(OCoLC)985626839
042 $apcc
050 00 $aQR414.6.H58$bH845 2002
060 00 $a2002 D-408
060 10 $aQW 168.5.H6$bH9179 2002
082 00 $a616.97/9201$221
245 04 $aThe human immunodeficiency virus :$bbiology, immunology, and therapy /$cEmilio A. Emini, editor.
260 $aPrinceton, N.J. :$bPrinceton University Press,$c©2002.
300 $axii, 532 pages :$billustrations ;$c26 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
505 00 $tThe structure and biology of HIV-1: introduction /$rElana Cherry and Mark A. Wainberg --$tThe genetics of HIV-1 /$rJon P. Anderson [and others] --- Nucleoside inhibitors of HIV reverse transcriptase and the problem of drug resistance /$rMatthias Götte, Shalom Spira, and Mark A. Wainberg --$tNon-nucleoside reverse transcriptase inhibitors of HIV-1 /$rJan Balzarini --$tHIV-1 protease inhibitors /$rJon H. Condra and Joseph P. Vacca --$tThe biology and biochemistry of integration as a target for chemotherapeutic intervention /$rDaria J. Hazuda --$tChemokine receptors in HIV infection and AIDS /$rNathaniel R. Landau --$tNovel HIV-1 therapeutic targets: regulatory functions /$rCatherine Ulich and Richard B. Gaynor --$tNovel HIV-1 therapeutic targets: accessory functions /$rMario Stevenson --$tThe interface between the pathogenesis and treatment of HIV infection /$rMark B. Feinberg --$tHIV prevention: implementing proven prevention interventions to control the global epidemic /$rChris Collins, Todd Summers, and Tom Coates --$tThe immunobiology of HIV-1 infection /$rNorman L. Letvin --$tHIV vaccines 2000: prospects and challenges /$rSpyros A. Kalams and Bruce D. Walker.
650 0 $aHIV (Viruses)
650 0 $aHIV infections$xMolecular aspects.
650 0 $aHIV infections$xImmunotherapy.
650 0 $aHIV infections$xPathogenesis.
650 12 $aHIV-1$ximmunology.
650 12 $aHIV-1$xchemistry.
650 22 $aHIV Infections$xtherapy.
650 6 $aVirus du sida.
650 6 $aInfections à VIH.
650 7 $aHIV infections$xPathogenesis.$2fast$0(OCoLC)fst00949893
650 7 $aHIV (Viruses)$2fast$0(OCoLC)fst00949837
856 41 $3Table of contents$uhttp://catdir.loc.gov/catdir/toc/prin031/2001096473.html
856 42 $3Publisher description$uhttp://catdir.loc.gov/catdir/description/prin022/2001096473.html
938 $aBaker & Taylor$bBKTY$c105.00$d105.00$i0691004544$n0003734064$sactive
938 $aBrodart$bBROD$n57339406$c$120.00
938 $aBaker and Taylor$bBTCP$n2001096473
938 $aIngram$bINGR$n9780691004549
938 $aYBP Library Services$bYANK$n1788838
029 1 $aAU@$b000023023500
029 1 $aAU@$b000023374268
029 1 $aIG#$b9780691004549
029 1 $aNLGGC$b239682157
029 1 $aNLM$b101141274
029 1 $aNZ1$b6524033
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 294 OTHER HOLDINGS